Yes, we really need you to take part. The definition of suspected PrAKI has been specifically designed to include sites without creatinine access. Clinical criteria, including oliguria, oedema, hypertension, and clinical suspicion, are sufficient for case inclusion. The reporting clinician's documented suspicion is accepted. Sites without creatinine testing are actively encouraged to join.

Yes, we are welcoming sites from anywhere around the world who meet the minimum requirements for participation. We will be proactive in reaching out to sites in low- and middle-income settings as this is where the literature suggests the highest burden of PrAKI is. However, we recognise there is a growing burden in high-income settings too, and also want to compare risk factors and outcomes in different resource settings.

Yes. The statement of interest form is the first step only and carries no obligation to participate. The study has been designed as a non-interventional service evaluation using anonymised routinely collected data, and under UK HRA and King's College London definitions does not require ethics review or approval. We recognise that governance classifications vary between countries. Sites are responsible for confirming their own local requirements before data collection begins. King's College London will provide supporting documentation to assist with any local approval process, and we do not anticipate significant barriers. If you are uncertain about your local requirements, please contact us and we will advise.

Yes, we would like to include all settings that care for women with PrAKI. We will work with you during the set-up time to understand the referral pathways to ensure women you are referring on for additional care are not included in both institutions.

No, we are focused on accurate data collection and therefore there is no minimum number of cases. It is important that all suspected cases are recorded. Sites with very low case volumes provide important data, particularly about settings where PrAKI may be underdiagnosed.

The data collection tool is in English, with a Google Translate widget to support completion in other languages. Prior to the data collection window opening, we will work with sites to ensure the data requirements are fully understood, using translators where needed.

Data entry is estimated at approximately 15–20 minutes per case. Any trained member of the clinical team may enter data, it does not need to be a doctor or senior clinician. Retrospective entry within the 4-week window is permitted. Sites will also be asked to provide a daily denominator of total women admitted during the first three weeks of their window. Attendance at a pre-collection webinar is strongly encouraged but not mandatory.

No, we are sorry there are no funds available to reimburse or incentivise sites to participate in this project, financial or otherwise. However, all involved in data collection will be listed as part of the PrAKI Global Snapshot working group and named on the website and in any future publication. All data collectors will be recognised as named collaborators, with PubMed-citable collaborator listing where possible. Eligibility for authorship of the primary manuscript will be determined by contribution; further details of the publication policy will be shared with confirmed sites.

Data will be handled in line with GDPR (the General Data Protection Regulation, the standard governing data privacy and security that this study adheres to). All data will be anonymised. Data will be shared at the end of the data collection period without declaration of the dates of data collection. Data will be hosted on a secure server managed by King’s College London. Access will be restricted to the core study team. Country and site identifiers will be collected to enable regional analysis, but no patient-level identifying data or dates of birth will be entered. Further information will be shared as available.

It is expected that this work will be published in a high-impact international peer-reviewed journal. The findings will be widely disseminated with the aim of generating more momentum with key stakeholders including policy makers, funders, industry, change makers and to guide implementation of interventions to prevent, diagnose and manage PrAKI more effectively.

No. There is no minimum case requirement and no penalty for low case numbers. The study is designed to capture the true global picture, including settings where PrAKI is rarely identified. Submitting accurate data, even for zero cases in a window, is valuable information.